We are live on ! Find out more
JFG

Jefferies Financial Group Portfolio holdings

AUM $14.6B
1-Year Est. Return 40.95%
This Fund
S&P 500
This Quarter Est. Return
+1.85%
1 Year Est. Return
+40.95%
3 Year Est. Return
+104.32%
5 Year Est. Return
+50.55%
10 Year Est. Return
+495.11%
AUM
$9.41B
AUM Growth
-$1.41B
Cap. Flow
-$1.76B
Cap. Flow %
-18.7%
Top 10 Hldgs %
34.48%
Holding
1,981
New
418
Increased
359
Reduced
342
Closed
619

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$151M
2
GLNG icon
Golar LNG
GLNG
+$80M
3
GERN icon
Geron
GERN
+$77.4M
4
BSX icon
Boston Scientific
BSX
+$47.4M
5
ABBV icon
AbbVie
ABBV
+$35.8M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$68.2M
2
DAL icon
Delta Air Lines
DAL
+$56M
3
ARGX icon
argenx
ARGX
+$51.7M
4
MRNA icon
Moderna
MRNA
+$48.7M
5
NVDA icon
NVIDIA
NVDA
+$46.4M

Sector Composition

Rank Sector Weight
1 Healthcare 11.12%
2 Technology 4.7%
3 Energy 4.53%
4 Industrials 3.84%
5 Consumer Discretionary 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARKF icon
1251
ARK Blockchain & Fintech Innovation ETF
ARKF
$744M
– –
-6,682
Closed -$203K
ARKK icon
1252
CALL
ARK Innovation ETF
ARKK
$5.74B
– –
-62,500
Closed -$3.13M
ARLO icon
1253
Arlo Technologies
ARLO
$1.55B
– –
-56,700
Closed -$717K
ARWR icon
1254
CALL
Arrowhead Research
ARWR
$12.1B
– –
-13,000
Closed -$372K
ASND icon
1255
Ascendis Pharma A/S
ASND
$16.7B
– –
-24,151
Closed -$3.65M
ATOS icon
1256
Atossa Therapeutics
ATOS
$24.1M
– –
-2,547
Closed -$68.8K
AURA icon
1257
Aura Biosciences
AURA
$729M
– –
-222,497
Closed -$1.75M
AVO icon
1258
CALL
Mission Produce
AVO
$1.13B
– –
-25,000
Closed -$297K
AVTR icon
1259
CALL
Avantor
AVTR
$8.48B
– –
-112,000
Closed -$2.86M
AVTR icon
1260
Avantor
AVTR
$8.48B
– –
-74,739
Closed -$1.91M
AWI icon
1261
Armstrong World Industries
AWI
$7.62B
– –
-5,808
Closed -$721K
AXTA icon
1262
Axalta
AXTA
$7.58B
– –
-9,044
Closed -$311K
AXTI icon
1263
AXT Inc
AXTI
$2.8B
– –
-22,200
Closed -$102K
BAM icon
1264
Brookfield Asset Management
BAM
$76.7B
– –
-225,000
Closed -$9.45M
BAX icon
1265
Baxter International
BAX
$12.6B
– –
-48,900
Closed -$2.09M
BBD icon
1266
Banco Bradesco
BBD
$38.3B
– –
-425,000
Closed -$1.22M
BBIO icon
1267
CALL
BridgeBio Pharma
BBIO
$16.8B
– –
-2,500
Closed -$77.3K
BBIO icon
1268
BridgeBio Pharma
BBIO
$16.8B
– –
-61,907
Closed -$1.91M
BBIO icon
1269
PUT
BridgeBio Pharma
BBIO
$16.8B
– –
-1,800
Closed -$55.7K
BBSI icon
1270
Barrett Business Services
BBSI
$1.01B
– –
-33,728
Closed -$1.07M
BDSX icon
1271
Biodesix
BDSX
$218M
– –
-570
Closed -$16.3K
BEAM icon
1272
Beam Therapeutics
BEAM
$2.7B
– –
-195,000
Closed -$6.44M
BF.B icon
1273
Brown-Forman Class B
BF.B
$13.3B
– –
-4,500
Closed -$232K
BHC icon
1274
PUT
Bausch Health
BHC
$1.69B
– –
-40,300
Closed -$428K
BHE icon
1275
Benchmark Electronics
BHE
$2.76B
– –
-21,015
Closed -$631K
49 50
51
52 53

Similar funds

HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
IFP
Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Jefferies Financial Group's Q2 2024 Portfolio in Review

As of Q2 2024, Jefferies Financial Group held 1,981 positions worth $9.41B, down 13% from $10.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Jefferies Financial Group withdrew a net $1.76B in Q2 2024, closing 619 positions and reducing 342 holdings. Its most notable exit was Osiris Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant, an estimated $24.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 8.4% a quarter earlier, followed by Technology and Energy.

Against the trend, Jefferies Financial Group opened a new position in Sprinklr worth $22.7M.

  • Jefferies Financial Group's largest Q2 2024 buy was Sprinklr: 2,355,000 shares worth $22.7M.
  • Jefferies Financial Group added most to State Street SPDR S&P 500 ETF Trust in Q2 2024, an estimated $151M increase.
  • Jefferies Financial Group's biggest Q2 2024 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $68.2M.
  • Jefferies Financial Group fully exited Osiris Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-half of one redeemable warrant in Q2 2024, selling an estimated $24.3M.
  • Jefferies Financial Group's ten largest holdings make up 34% of its $9.41B portfolio in Q2 2024.
  • Jefferies Financial Group opened 418 new positions and closed 619 in Q2 2024.
  • Jefferies Financial Group's portfolio value fell 13% quarter-over-quarter to $9.41B.

Based on Jefferies Financial Group's 13F filing for Q2 2024, filed 13 Aug 2024.